Fresenius Invests in Avelios Medical HealthTech

German healthcare giant Fresenius has injected capital into Avelios Medical, a HealthTech firm focused on optimizing hospital information systems. This strategic investment underscores Fresenius' commitment to advancing digital healthcare infrastructure within Germany, building on prior collaborations with software titan SAP aimed at accelerating digital health solutions.

Founded in 2020 by Nicolas Jakob, Sebastian Krammer, and Christian Albrecht, Avelios Medical develops a hospital information system designed to streamline clinical workflows, reduce administrative burdens, and intelligently connect patient data from admission through to billing. The company's technology addresses a critical need in the healthcare sector for more efficient data management and operational processes, a market segment experiencing significant digital transformation.

The newly acquired funding will be strategically deployed by Avelios Medical to bolster its team, enhance product development, and strengthen delivery capabilities. This focus is intended to accelerate the company's ability to execute large-scale rollouts for enterprise clients, positioning it for significant growth in the competitive HealthTech arena. This move aligns with broader industry trends where integrated digital solutions are becoming essential for healthcare providers.

This latest backing follows a substantial €30 million funding round previously secured by Avelios Medical, which saw participation from prominent investors including Sequoia Capital, Revent, and the High-Tech Gründerfonds (HTGF). The continued influx of capital from both strategic corporate players and established venture capital firms highlights strong confidence in Avelios Medical's vision and market potential.

The HealthTech sector, particularly solutions enhancing hospital efficiency and patient data management, is a key area of focus for investors. The global digital health market is projected to grow substantially in the coming years, driven by increasing demand for personalized medicine, remote patient monitoring, and improved healthcare accessibility. Avelios Medical's platform is well-positioned to capitalize on these trends.

In related HealthTech developments, ViViRA, a company specializing in digital therapeutics for musculoskeletal health, has also secured funding from investors including IBB Capital and Bonventure. Separately, Onyx Biotech, which develops digital solutions for optimizing process engineering in the pharmaceutical, biotech, and chemical industries, has received investment from Life Science Valley Wachstumsfonds and Freiraum Ventures, signaling continued robust investment activity across various sub-sectors of HealthTech.